MDT

89.55

+0.53%↑

VEEV

278.13

-2.64%↓

A

122.12

+0.8%↑

WBA

11.52

-0.52%↓

HQY

95.66

-3.47%↓

MDT

89.55

+0.53%↑

VEEV

278.13

-2.64%↓

A

122.12

+0.8%↑

WBA

11.52

-0.52%↓

HQY

95.66

-3.47%↓

MDT

89.55

+0.53%↑

VEEV

278.13

-2.64%↓

A

122.12

+0.8%↑

WBA

11.52

-0.52%↓

HQY

95.66

-3.47%↓

MDT

89.55

+0.53%↑

VEEV

278.13

-2.64%↓

A

122.12

+0.8%↑

WBA

11.52

-0.52%↓

HQY

95.66

-3.47%↓

MDT

89.55

+0.53%↑

VEEV

278.13

-2.64%↓

A

122.12

+0.8%↑

WBA

11.52

-0.52%↓

HQY

95.66

-3.47%↓

Search

Assertio Holdings Inc

Abierto

0.69

Resumen

Variación precio

24h

Actual

Mínimo

0.68

Máximo

0.72

Métricas clave

By Trading Economics

Ingresos

-3.1M

-14M

Ventas

-5.7M

26M

Margen de beneficio

-51.121

Empleados

58

EBITDA

-10M

-13M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+250.72% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

3.9M

63M

Apertura anterior

0.69

Cierre anterior

0.69

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Assertio Holdings Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

10 jul 2025, 21:42 UTC

Adquisiciones, fusiones, absorciones

Justice Department Won't Seek Injunction for T-Mobile Acquisition of U.S. Cellular

10 jul 2025, 17:06 UTC

Adquisiciones, fusiones, absorciones

Portugal Begins Process to Sell Stake in National Carrier -- Update

10 jul 2025, 17:00 UTC

Principales Movimientos del Mercado

K Wave Media Shares Drop After Convertible Note Agreement With Anson Funds

10 jul 2025, 16:31 UTC

Adquisiciones, fusiones, absorciones

Blackstone Makes $664 Million Counteroffer for Warehouse REIT Amid Bidding War -- 2nd Update

10 jul 2025, 23:47 UTC

Charlas de Mercado

Gold Edges Higher Amid Lingering Global Trade Tensions -- Market Talk

10 jul 2025, 23:40 UTC

Charlas de Mercado

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

10 jul 2025, 22:36 UTC

Charlas de Mercado

Tourism Holdings' Profit Warning Less Concerning Than Others -- Market Talk

10 jul 2025, 22:23 UTC

Charlas de Mercado

New Law Creates Winners and Losers Among Renewable-Energy Projects -- Market Talk

10 jul 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

10 jul 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

10 jul 2025, 20:00 UTC

Adquisiciones, fusiones, absorciones

Toyota Tsusho America Completes Acquisition of Radius Recycling

10 jul 2025, 19:56 UTC

Charlas de Mercado

Gold Rises on Inflation Concerns -- Market Talk

10 jul 2025, 19:33 UTC

Charlas de Mercado

Oil Snaps Winning Streak As Oversupply Concerns Return -- Market Talk

10 jul 2025, 19:21 UTC

Charlas de Mercado

U.S. Natural Gas Rebound on Benign Storage Build -- Market Talk

10 jul 2025, 18:46 UTC

Charlas de Mercado

Mexican Industrial Production Seen as Mixed in May -- Market Talk

10 jul 2025, 18:15 UTC

Charlas de Mercado

Brazil's Bullish Outlook Expected to Survive Trump Tariffs -- Market Talk

10 jul 2025, 18:03 UTC

Charlas de Mercado
Ganancias

Travel Agency Investors Cautiously Optimistic After Delta Report -- Market Talk

10 jul 2025, 17:57 UTC

Charlas de Mercado

US Labor Shortage Could Weigh on Business, Economic Growth -- Market Talk

10 jul 2025, 17:34 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Conagra Falls While Simply Good Foods Adapts. What's Eating Food Companies. -- Barrons.com

10 jul 2025, 17:34 UTC

Charlas de Mercado

Canada Vows Fight Over Trump's Copper Tariffs -- Market Talk

10 jul 2025, 17:20 UTC

Charlas de Mercado

Copper Climbs as Futures Wrangle With Trump Tariff -- Market Talk

10 jul 2025, 17:20 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

10 jul 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

10 jul 2025, 16:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

10 jul 2025, 16:20 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

10 jul 2025, 16:02 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

10 jul 2025, 16:02 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

10 jul 2025, 16:02 UTC

Charlas de Mercado

Embraer Expected to Bear Brunt of U.S. Tariffs on Brazil -- Market Talk

10 jul 2025, 16:01 UTC

Adquisiciones, fusiones, absorciones

Investor AB: Advanced Instruments' Acquisition of Nova Biomedical Completed

10 jul 2025, 15:41 UTC

Charlas de Mercado

U.S. Natural Gas Storage Surplus Holds Steady -- Market Talk

Comparación entre iguales

Cambio de precio

Assertio Holdings Inc Esperado

Precio Objetivo

By TipRanks

250.72% repunte

Estimación a 12 meses

Media 2.42 USD  250.72%

Máximo 3.5 USD

Mínimo 0.5 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Assertio Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

4

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

0.618 / 0.649Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.